Identification of Baicalin as an immunoregulatory compound by controlling T(H)17 cell differentiation.
T(H)17 cells have been implicated in a growing list of inflammatory disorders. Antagonism of T(H)17 cells can be used for the treatment of inflammatory injury. Currently, very little is known about the natural compound controlling the differentiation of T(H)17 cells. Here, we showed that Baicalin, a...
Main Authors: | Ji Yang, Xue Yang, Yiwei Chu, Ming Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3040219?pdf=render |
Similar Items
-
Baicalin, a natural compound, promotes regulatory T cell differentiation
by: Yang Ji, et al.
Published: (2012-05-01) -
Baicalin Inhibits IL-17-Mediated Joint Inflammation in Murine Adjuvant-Induced Arthritis
by: Xue Yang, et al.
Published: (2013-01-01) -
Mechanisms behind the Immunoregulatory Dialogue between Mesenchymal Stem Cells and Th17 Cells
by: Claudia Terraza-Aguirre, et al.
Published: (2020-07-01) -
Immunoregulatory Cells in Myasthenia Gravis
by: Ying Wu, et al.
Published: (2020-12-01) -
Baicalin Attenuates IL-17-Mediated Acetaminophen-Induced Liver Injury in a Mouse Model.
by: Chia-Chih Liao, et al.
Published: (2016-01-01)